about
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX sInhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Colorectal cancer: integrating oxaliplatin.
@ast
Colorectal cancer: integrating oxaliplatin.
@en
type
label
Colorectal cancer: integrating oxaliplatin.
@ast
Colorectal cancer: integrating oxaliplatin.
@en
prefLabel
Colorectal cancer: integrating oxaliplatin.
@ast
Colorectal cancer: integrating oxaliplatin.
@en
P1476
Colorectal cancer: integrating oxaliplatin.
@en
P2093
Christophe Louvet
P2888
P304
P356
10.1007/S11864-003-0041-8
P577
2003-10-01T00:00:00Z